eContouring for Glioblastoma Webinar
GBM patients with LMD are a subgroup of GBM patients with distinctly poor prognosis. That being said, treatment options should be considered based on different clinical factors. In this eContouring webinar, we will review how to approach these treatment options in a patient-by-patient basis. We will also review general contouring guidelines for GBM, as well as how we may adjust our contours with the presence of LMD.
This activity includes a live webinar didactic background lecture and case/contour review. Participants also have access to the online contouring platform approximately two weeks prior to the webinar to contour practice cases prepared by the faculty and receive a metric score based on the accuracy of their contour(s) compared to the faculty.
CME credits for this webinar must be claimed by Friday, January 16 , 2026.
The webinar is sponsored by the ROI Juan A. del Regato Fund. The ROI is ASTRO’s Research Foundation, and more information can be found at roinstitute.org.
Target Audience
This course is designed to meet the interest of radiation oncologists and radiation oncology residents.
Learning Objectives
Upon completion of this live activity, participants should be able to:
- Identify treatment options for GBM patients with LMD, be able to taylor these options based on clinical factors.
- Explain general contouring guidelines for GBM patients, and how you may adjust contours with the presence of LMD.
Planners
Salma Jabbour, MD, FASTRO, is employed by Rutgers Cancer Institute and receives funding from Merck & Co., Inc, Beigene, Radialogica, IMX Medical, Dechert LLC, AstraZeneca. She serves in a leadership position with the International Journal of Radiation Oncology, Biology, Physics (IJROBP)
Manisha Palta, MD, is employed by Duke University and receives research funding from Merck and Varian Medical Systems. She is a consultant for Varian Medical Systems, Voxelmetric and Syntaxtx and serves on an advisory board for Varian Medical Systems.
Faculty
Elham Rahimy, MD, is employed by Stanford University.
The person(s) above served as the developer(s) of this activity. Additionally, the ASTRO Education Committee had control over the content of this activity.
All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
Price
Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
- Nonmember: $179
- Member: $119
- Member-in-Training: Free
If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until December 17, 2026, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.

Facebook
X
LinkedIn
Forward